Emina Huang, M.D.

Staff

Center for Cancer Stem Cell Research

Lerner Research Institute, 9500 Euclid Avenue, Cleveland, Ohio 44195
Location: NE6-203
Email: huange2@ccf.org
Phone: (216) 445-4631
Fax: (216) 636-5454

 


The development of cancer in the face of chronic inflammation has long been recognized. However, the precise pathogenetic mechanisms have been poorly defined. Our laboratory seeks to define how elements of the epithelia and the surrounding microenvironment interact to promote progression to cancer, or conversely, to mitigate the progression. We have unique tools derived directly from patients, as well as unique models, including colitis-derived tumor initiating cells and colitis-derived fibroblasts. The laboratory interrogates the relationships to understand the progression to delineate unique targets and mechanisms to both prevent the inexorable progression along with the devastating symptoms.


Robert  Fisher  PhD Robert Fisher, PhD
Lead Research Technologist
Location:NE6-214
Phone:(216) 442-5092
fisherr7@ccf.org
Samaneh  Kamali  PhD Samaneh Kamali, PhD
Postdoctoral Research Fellow
Location:NE6-214
Phone:(216) 442-5092
kamalis@ccf.org

  1. Dalerba P, Dylla SJ, Park, IK, Liu, R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF. Phenotypic characterization of human colorectal “cancer stem cells”. PNAS 2007;104:10158-63. PMC1891215.
  2. Shenoy AK, Fisher RC, Butterworth EA, Pi L, Chang LJ, Appelman HD, Chang M, Scott EW, Huang EH. Transition from colitis to cancer: High Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors. Cancer Research  2012 Oct 1; 72:5091-5100. PMC3463774.
  3. Fearon ER, Huang EH.  CDX2: Linking cell and patient fates in colon cancer. Cell Stem Cell 2016 18(2):168-9. PMID 26849302.
  4. Chen HJ, Wei Z, Sun J, Bhattacharya A, Savage DJ, Serda R, Mackeyev Y, Curley SA, Bu P, Wang L, Chen S, Cohen-Gould L, Huang E, Shen X, Lipkin SM, Copeland NG, Jenkins NA, Shuler ML. Engineering an organotypic colon through recellularization for studying cancer driver genes using transposon-based mutagenesis.  Nat Biotech 2016 Aug;34(8):845-51.
  5. Chen S, Fisher RC, Signs S, Molina LA, Shenoy AK, Lopez MC, Baker HV, Koomen JM, Gittleman H, Barnholtz-Sloan J, Berg A, Appelman HD, Huang EH. Inhibition of PI3K/Akt/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis. Oncotarget, 2016, epub June 8, in press.


10/12/2018 |  

Researchers Build “Mini-Colon” to Study Inflammatory Bowel Disease, Cancer

Last year, Cleveland Clinic researcher Emina Huang, MD, was awarded a collaborative, multi-million dollar grant from the National Cancer Institute (NCI) to create innovative disease models of colorectal cancer. In less than a year, she has already harnessed this support into new discoveries that will enhance the understanding of the disease.